Tata Capital Healthcare Fund II (TCHF II), the healthcare focused private equity fund of Tata Capital, has invested an amount of upto $10 million in Apex Kidney Care (AKC) for an undisclosed equity stake. AKC is India’s second largest dialysis chain in the country and will utilise the newly infused capital to expand its dialysis services across the country. 

India has an estimated 2 million Chronic Kidney Disease (CKD) Stage -5 patients (kidney function below 15%). There are 0.2 million to 0.22 million CKD-5 patients getting added annually. Currently, ~21 million dialysis sessions are conducted on an annual basis in India, and this is estimated to be an abysmal ~11% of the overall annual need of the country. This indicates a significant need gap caused due to a combination of accessibility, affordability and compliance challenges.  

Dr Jatin Kothari, Co-founder and Director, Apex Kidney Care said, “This new partnership underscores the value of our business model and our vision in delivering high quality dialysis services. The combined strength promises to open many new avenues to advance the business, and favorably touch the lives of thousands of patients fighting kidney disease."